- Home
- KNSL vs PCVX Comparison
KNSL vs PCVX Comparison
Compare KNSL & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSL
- PCVX
- Stock Information
- Founded
- KNSL 2009
- PCVX 2013
- Country
- KNSL United States
- PCVX United States
- Employees
- KNSL N/A
- PCVX N/A
- Industry
- KNSL Property-Casualty Insurers
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- KNSL Finance
- PCVX Health Care
- Exchange
- KNSL Nasdaq
- PCVX Nasdaq
- Market Cap
- KNSL 11.0B
- PCVX 13.2B
- IPO Year
- KNSL 2016
- PCVX 2020
- Fundamental
- Price
- KNSL $465.20
- PCVX $86.51
- Analyst Decision
- KNSL Hold
- PCVX Strong Buy
- Analyst Count
- KNSL 8
- PCVX 7
- Target Price
- KNSL $463.43
- PCVX $147.50
- AVG Volume (30 Days)
- KNSL 164.5K
- PCVX 1.4M
- Earning Date
- KNSL 10-24-2024
- PCVX 11-05-2024
- Dividend Yield
- KNSL 0.13%
- PCVX N/A
- EPS Growth
- KNSL 50.01
- PCVX N/A
- EPS
- KNSL 17.53
- PCVX N/A
- Revenue
- KNSL $1,526,573,000.00
- PCVX N/A
- Revenue This Year
- KNSL N/A
- PCVX N/A
- Revenue Next Year
- KNSL $16.76
- PCVX N/A
- P/E Ratio
- KNSL $26.54
- PCVX N/A
- Revenue Growth
- KNSL 36.12
- PCVX N/A
- 52 Week Low
- KNSL $325.01
- PCVX $48.24
- 52 Week High
- KNSL $548.47
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- KNSL 54.52
- PCVX 23.31
- Support Level
- KNSL $467.98
- PCVX $101.87
- Resistance Level
- KNSL $484.56
- PCVX $107.31
- Average True Range (ATR)
- KNSL 11.66
- PCVX 5.82
- MACD
- KNSL 4.31
- PCVX -2.04
- Stochastic Oscillator
- KNSL 70.11
- PCVX 3.58
About KNSL Kinsale Capital Group Inc.
Kinsale Capital Group Inc is an insurance holding company. The company is engaged in offering property, casualty, and specialty insurance products. It offers specialty insurance products for allied health, healthcare, life sciences, a professional, and a public entity. The company operates in only one reportable segment which is the Excess and Surplus Lines Insurance segment, which includes commercial excess and surplus lines liability and property insurance products through its underwriting divisions. The company generates revenues in the form of premiums and investment income.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.